Copertina

Letter: Shorter duration of intravenous terlipressin for variceal bleeding in patients with cirrhosis—A promising find

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Leya Nedumannil, Mustafa Mohamedrashed, Siddharth Sood, Diana Lewis
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Alimentary Pharmacology & Therapeutics
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Letter: Shorter duration of intravenous terlipressin for variceal bleeding in patients with cirrhosis—A promising find. Author's reply
di: Sagnik Biswas, et al.
Pubblicazione: (2024)

Letter: The enigma of angiotensin receptor blocker‐associated enteropathy
di: Mustafa Mohamedrashed, et al.
Pubblicazione: (2024)

Editorial: Shorter course of intravenous terlipressin in acute variceal bleeding—the promise, controversies and future directions. Author's reply
di: Sagnik Biswas, et al.
Pubblicazione: (2024)

Letter: Association between terlipressin and multi‐drug‐resistant organism rectal colonisation
di: Katrina Tan, et al.
Pubblicazione: (2024)

Letter: Association between terlipressin and multidrug‐resistant organism rectal colonization: Authors' reply
di: Marcus M. Mücke, et al.
Pubblicazione: (2024)

Letter: Bisphosphonate effectiveness in patients with cirrhosis—An emulated clinical trial
di: Mingsi Zhang, et al.
Pubblicazione: (2024)

Letter: Steroid Tapering—Is Shorter Duration Better?
di: Juntao Lu, et al.
Pubblicazione: (2026)

Letter: Association of polymorphic variant of SerpinB3 and faster cirrhosis decompensation in patients with cirrhosis—More evidence needed
di: Haibo Jing, et al.
Pubblicazione: (2024)

Letter: Bisphosphonate effectiveness in patients with cirrhosis—an emulated clinical trial. Authors' reply
di: Elliot B. Tapper, et al.
Pubblicazione: (2024)

Letter: Association of polymorphic variant of SerpinB3 and faster cirrhosis decompensation in patients with cirrhosis—More evidence needed. Authors' reply
di: Andrea Martini, et al.
Pubblicazione: (2024)

Letter: Use of liver stiffness measurement to identify liver cirrhosis in patients with chronic hepatitis D
di: Jian Wang, et al.
Pubblicazione: (2024)

Letter: Over‐the‐scope clips in patients at high risk of re‐bleeding following upper gastrointestinal tract bleeding—The magic bullet for everyone?
di: Gabriel Allo, et al.
Pubblicazione: (2024)

Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis—Authors' reply
di: Lukas Burghart, et al.
Pubblicazione: (2024)

Letter: Enhancing cirrhosis management—The critical role of social workers in supporting NAFLD surveillance
di: Senlin Ye, et al.
Pubblicazione: (2024)

Bisphosphonate effectiveness in patients with cirrhosis: An emulated clinical trial
di: Elliot B. Tapper, et al.
Pubblicazione: (2024)

Editorial: Revisit the causes and long‐term outcomes in cirrhosis patients
di: Ming‐Lun Yeh, et al.
Pubblicazione: (2024)

Review article: Evaluation and care of the critically ill patient with cirrhosis
di: Iva Kosuta, et al.
Pubblicazione: (2024)

Letter: Post‐endoscopic management after upper gastrointestinal bleeding—Replenishment of iron loss
di: Palle Bager, et al.
Pubblicazione: (2024)

Letter: Reflections on the role of over‐the‐scope clips in high‐risk upper gastrointestinal bleeding
di: Yajie Wang, et al.
Pubblicazione: (2024)

Letter: Over‐the‐scope clips in patients at high risk of rebleeding following upper gastrointestinal tract bleeding—The magic bullet for everyone? Authors'reply
di: Kai Song, et al.
Pubblicazione: (2024)

Editorial: Revisit the causes and long‐term outcomes in cirrhosis patients—Authors' reply
di: Linda Henry, et al.
Pubblicazione: (2024)

Editorial: Novel insights into the prognostic relevance of high‐dose PPI treatment in patients with cirrhosis
di: Dominik Bettinger, et al.
Pubblicazione: (2024)

Terlipressin therapy is associated with increased risk of colonisation with multidrug‐resistant bacteria in patients with decompensated cirrhosis
di: Marcus M. Mücke, et al.
Pubblicazione: (2024)

Repeatability of vibration‐controlled transient elastography versus magnetic resonance elastography in patients with cirrhosis: A prospective study
di: Harris Siddiqi, et al.
Pubblicazione: (2024)

Editorial: Non‐selective beta‐blockers: A lifesaving shield for critically ill patients with acute decompensation of cirrhosis?
di: Ling Yang, et al.
Pubblicazione: (2024)

The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetes
di: Lana Bridi, et al.
Pubblicazione: (2024)

Prevalence and prognosis of patients with MASLD ‐related cirrhosis after an ICU hospitalization in France: A single‐centre prospective study
di: Philippe Sultanik, et al.
Pubblicazione: (2024)

Non‐selective beta‐blocker is associated with reduced mortality in critically ill patients with cirrhosis: A real‐world study
di: Rahul Kumar, et al.
Pubblicazione: (2024)

Editorial: Reading the cholate – A new gateway to portal hypertension and oesophageal varices
di: Iulia Minciuna, et al.
Pubblicazione: (2024)

Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infection
di: Lisa Sandmann, et al.
Pubblicazione: (2024)

Editorial: Terlipressin and MDRO colonisation in cirrhosis—Is there a causal link?
di: Luciano Revelli, et al.
Pubblicazione: (2024)

Editorial: Reading the cholate—A new gateway to portal hypertension and oesophageal varices: Authors' reply
di: Tarek Hassanein, et al.
Pubblicazione: (2024)

Review article: Recent advances in ascites and acute kidney injury management in cirrhosis
di: Danielle Adebayo, et al.
Pubblicazione: (2024)

Letter: Risks of proton pump inhibitor treatment in cirrhotic patients
di: Jiamei Wang, et al.
Pubblicazione: (2024)

Letter: Addressing opioid exposure and associated harms in patients with IBD
di: Christian P. Selinger, et al.
Pubblicazione: (2024)

A personalised algorithm predicting the risk of intravenous corticosteroid failure in acute ulcerative colitis
di: Anthony Croft, et al.
Pubblicazione: (2024)

Editorial: Incidence and predictors of major gastrointestinal bleeding in patients on aspirin, low‐dose rivaroxaban or the combination: Secondary analysis of the COMPASS randomised controlled trial
di: Kanika Sehgal, et al.
Pubblicazione: (2024)

Liver function and portal‐systemic shunting quantified by the oral cholate challenge test and risk for large oesophageal varices
di: Tarek Hassanein, et al.
Pubblicazione: (2024)

Letter: Impact of antiviral treatment on renal function in patients with chronic hepatitis B
di: Jian Wang, et al.
Pubblicazione: (2024)

Letter: Prioritising osteosarcopenia assessment in the ongoing care of patients with cholestatic liver diseases
di: Ivan Arcari, et al.
Pubblicazione: (2024)